Technology
Health
Biotechnology
Cyclacel Pharmaceuticals
$1.019876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.14 (15.86%) Today
+$0.01 (1.00%) After Hours
Why Robinhood?
You can buy or sell CYCC and other stocks, options, ETFs, and crypto commission-free!
About
Cyclacel Pharmaceuticals, Inc. Common Stock, also called Cyclacel Pharmaceuticals, is a clinical-stage biopharmaceutical company. Read More It uses cell cycle, transcriptional regulation and DNA damage response biology to develop innovative, targeted medicines for cancer and other proliferative diseases. The company builds a diversified biopharmaceutical business, which is focused in hematology and oncology based on a pipeline of novel drug candidates. Its products includes CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.
Employees
12
Headquarters
Berkeley Heights, New Jersey
Founded
1996
Market Cap
10.36M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
184.43K
High Today
$1.03
Low Today
$0.855
Open Price
$0.87
Volume
1.17M
52 Week High
$1.87
52 Week Low
$0.51
Collections
Technology
Health
Biotechnology
Biopharmaceutical
Medical
Cancer Prevention
Pharmaceutical
US
News
Simply Wall StMar 12
Should You Be Pleased About The CEO Pay At Cyclacel Pharmaceuticals, Inc.’s (NASDAQ:CYCC)
Spiro Rombotis became the CEO of Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) in 1997. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. Then we’ll look at a snap shot of the business growth. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO. Check out our latest...
Price Paid on Robinhood
17% Lower
Right Now
52 Week Low
$0.51
Average Price Paid
$1.22
52 Week High
$1.87
Earnings
-$0.50
-$0.30
-$0.09
$0.11
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
Available Mar 27, After Hours